Tapewire

Nasdaq · USD

UTHR

UNITED THERAPEUTICS Corp

Export transactions ↓
Tapewire entity
664
SEC CIK
0001082554
Parsed reports
1,261

Last 12 months

Inside the activity.

1 purchase rows · 2632 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 20250142
Dec 20250143
Jan 2026078
Feb 2026026
Mar 20260364
Apr 20260346
May 20261340
Jun 20260298
Jul 20260240
Aug 20260251
Sep 20260260
Oct 20260144

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 06, 2026 Filed Mar 10, 2026 20:33 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 284 $471.96 $134,037.83
Disclosure

SEC source: 0001106578-26-000006 · primarydocument.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,346

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $471.56 to $472.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 06, 2026 Filed Mar 10, 2026 20:33 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
Exercise / conversionCommon Stock 9,500 $146.03 $1,387,285.00
Disclosure

SEC source: 0001106578-26-000006 · primarydocument.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,630

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 21:37 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
Exercise / conversionStock Option · Derivative 8,300 $0.00 Strike: $146.03 $0.00
Disclosure

SEC source: 0001231589-26-000006 · primarydocument.xml · derivative · entry 11

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,500

Underlying: Common Stock · 8,300 shares

Expires 2027-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 21:37 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 200 $487.65 $97,530.40
Disclosure

SEC source: 0001231589-26-000006 · primarydocument.xml · nonDerivative · entry 10

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,844

F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

F11 · price: This transaction was executed in multiple trades at prices ranging from $487.475 to $487.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 21:37 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 743 $486.52 $361,482.13
Disclosure

SEC source: 0001231589-26-000006 · primarydocument.xml · nonDerivative · entry 9

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,044

F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

F10 · price: This transaction was executed in multiple trades at prices ranging from $486.41 to $486.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 21:37 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 1,006 $485.32 $488,235.54
Disclosure

SEC source: 0001231589-26-000006 · primarydocument.xml · nonDerivative · entry 8

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,787

F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

F9 · price: This transaction was executed in multiple trades at prices ranging from $485.10 to $485.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 21:37 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 1,398 $484.55 $677,402.58
Disclosure

SEC source: 0001231589-26-000006 · primarydocument.xml · nonDerivative · entry 7

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,793

F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

F8 · price: This transaction was executed in multiple trades at prices ranging from $484.07 to $484.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 21:37 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 1,086 $483.54 $525,123.46
Disclosure

SEC source: 0001231589-26-000006 · primarydocument.xml · nonDerivative · entry 6

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,191

F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

F7 · price: This transaction was executed in multiple trades at prices ranging from $483.07 to $484.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 21:37 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 1,177 $482.68 $568,114.48
Disclosure

SEC source: 0001231589-26-000006 · primarydocument.xml · nonDerivative · entry 5

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,277

F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

F6 · price: This transaction was executed in multiple trades at prices ranging from $482.025 to $482.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 21:37 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 720 $481.33 $346,559.18
Disclosure

SEC source: 0001231589-26-000006 · primarydocument.xml · nonDerivative · entry 4

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,454

F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

F5 · price: This transaction was executed in multiple trades at prices ranging from $481.02 to $481.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 21:37 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 1,602 $480.22 $769,310.20
Disclosure

SEC source: 0001231589-26-000006 · primarydocument.xml · nonDerivative · entry 3

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,174

F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

F4 · price: This transaction was executed in multiple trades at prices ranging from $479.82 to $480.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 21:37 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 368 $479.43 $176,429.17
Disclosure

SEC source: 0001231589-26-000006 · primarydocument.xml · nonDerivative · entry 2

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,776

F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $478.82 to $479.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 21:37 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
Exercise / conversionCommon Stock 8,300 $146.03 $1,212,049.00
Disclosure

SEC source: 0001231589-26-000006 · primarydocument.xml · nonDerivative · entry 1

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,144

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

F2 · balance_after: Includes 63 shares of common stock acquired on March 4, 2026 under the United Therapeutics Employee Stock Purchase Plan.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
Exercise / conversionStock Options · Derivative 9,500 $0.00 Strike: $146.03 $0.00
Disclosure

SEC source: 0001106578-26-000005 · primarydocument.xml · derivative · entry 16

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 202,000

Underlying: Common Stock · 9,500 shares

Expires 2027-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 587 $487.98 $286,445.02
Disclosure

SEC source: 0001106578-26-000005 · primarydocument.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F10 · price: This transaction was executed in multiple trades at prices ranging from $487.67 to $488.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 1,199 $487.02 $583,937.70
Disclosure

SEC source: 0001106578-26-000005 · primarydocument.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 717

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F9 · price: This transaction was executed in multiple trades at prices ranging from $486.62 to $487.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 798 $486.20 $387,990.23
Disclosure

SEC source: 0001106578-26-000005 · primarydocument.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,916

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F8 · price: This transaction was executed in multiple trades at prices ranging from $485.61 to $486.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 2,625 $485.00 $1,273,120.80
Disclosure

SEC source: 0001106578-26-000005 · primarydocument.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,714

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F7 · price: This transaction was executed in multiple trades at prices ranging from $484.61 to $485.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 1,728 $484.05 $836,435.12
Disclosure

SEC source: 0001106578-26-000005 · primarydocument.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,339

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F6 · price: This transaction was executed in multiple trades at prices ranging from $483.53 to $484.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 1,293 $482.93 $624,422.03
Disclosure

SEC source: 0001106578-26-000005 · primarydocument.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,067

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F5 · price: This transaction was executed in multiple trades at prices ranging from $482.52 to $483.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 510 $482.05 $245,844.43
Disclosure

SEC source: 0001106578-26-000005 · primarydocument.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,360

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F4 · price: This transaction was executed in multiple trades at prices ranging from $481.52 to $482.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 481 $480.56 $231,148.45
Disclosure

SEC source: 0001106578-26-000005 · primarydocument.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,870

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F3 · price: This transaction was executed in multiple trades at prices ranging from $480.28 to $481.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 279 $479.89 $133,888.50
Disclosure

SEC source: 0001106578-26-000005 · primarydocument.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,351

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $479.14 to $480.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
Exercise / conversionCommon Stock 9,500 $146.03 $1,387,285.00
Disclosure

SEC source: 0001106578-26-000005 · primarydocument.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,630

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
KURZWEIL RAYDirector
Exercise / conversionStock Option · Derivative 4,910 $0.00 Strike: $101.80 $0.00
Disclosure

SEC source: 0001108501-26-000001 · primarydocument.xml · derivative · entry 3

KURZWEIL RAY · CIK 0001108501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,910 shares

Expires 2026-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
KURZWEIL RAYDirector
SaleCommon Stock 4,910 $489.02 $2,401,088.20
Disclosure

SEC source: 0001108501-26-000001 · primarydocument.xml · nonDerivative · entry 2

KURZWEIL RAY · CIK 0001108501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,670

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
KURZWEIL RAYDirector
Exercise / conversionCommon Stock 4,910 $101.80 $499,838.00
Disclosure

SEC source: 0001108501-26-000001 · primarydocument.xml · nonDerivative · entry 1

KURZWEIL RAY · CIK 0001108501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,580

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
Exercise / conversionStock Options · Derivative 9,500 $0.00 Strike: $146.03 $0.00
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · derivative · entry 18

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,500

Underlying: Common Stock · 9,500 shares

Expires 2027-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 40 $497.05 $19,882.00
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 480 $495.78 $237,976.42
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 170

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F11 · price: This transaction was executed in multiple trades at prices ranging from $495.39 to $496.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 215 $494.74 $106,368.91
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 650

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F10 · price: This transaction was executed in multiple trades at prices ranging from $494.28 to $495.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 185 $493.40 $91,278.61
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 865

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F9 · price: This transaction was executed in multiple trades at prices ranging from $493.23 to $493.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 243 $492.44 $119,662.63
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,050

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F8 · price: This transaction was executed in multiple trades at prices ranging from $492.12 to $492.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 485 $491.33 $238,296.26
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,293

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F7 · price: This transaction was executed in multiple trades at prices ranging from $491.10 to $492.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 1,808 $490.52 $886,857.81
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,778

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F6 · price: This transaction was executed in multiple trades at prices ranging from $490.08 to $491.045. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 2,290 $489.68 $1,121,366.51
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,586

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F5 · price: This transaction was executed in multiple trades at prices ranging from $489.08 to $490.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 2,429 $488.63 $1,186,881.78
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,876

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F4 · price: This transaction was executed in multiple trades at prices ranging from $488.07 to $489.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 926 $487.55 $451,474.91
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,305

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F3 · price: This transaction was executed in multiple trades at prices ranging from $487.05 to $488.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 399 $486.42 $194,082.74
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,231

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $486.01 to $486.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:36 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 9,500 $146.03 $1,387,285.00
Disclosure

SEC source: 0001106578-26-000004 · primarydocument.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,630

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:35 UTC Exercise / conversionStock Option · Derivative 2,000 $0.00 Strike: $101.80 $0.00
Disclosure

SEC source: 0001324863-26-000001 · primarydocument.xml · derivative · entry 5

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2026-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:35 UTC SaleCommon Stock 2,000 $489.42 $978,839.40
Disclosure

SEC source: 0001324863-26-000001 · primarydocument.xml · nonDerivative · entry 2

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,480

F2 · price: This transaction was executed in multiple trades at prices ranging from $488.95 to $489.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: Includes 880 shares of common stock to be issued on or about July 8, 2026, as the result of the July 7, 2023 vesting of RSUs for which the reporting person elected to defer receipt of shares.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:35 UTC Exercise / conversionCommon Stock 2,000 $101.80 $203,600.00
Disclosure

SEC source: 0001324863-26-000001 · primarydocument.xml · nonDerivative · entry 1

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,480

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 880 shares of common stock to be issued on or about July 8, 2026, as the result of the July 7, 2023 vesting of RSUs for which the reporting person elected to defer receipt of shares.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:34 UTC Exercise / conversionStock Option · Derivative 20 $0.00 Strike: $119.76 $0.00
Disclosure

SEC source: 0001237334-26-000004 · primarydocument.xml · derivative · entry 3

CAUSEY CHRISTOPHER · CIK 0001237334 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,300

Underlying: Common Stock · 20 shares

Expires 2030-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:34 UTC SaleCommon Stock 20 $490.17 $9,803.37
Disclosure

SEC source: 0001237334-26-000004 · primarydocument.xml · nonDerivative · entry 2

CAUSEY CHRISTOPHER · CIK 0001237334 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,190

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $490.12 to $490.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 21:34 UTC Exercise / conversionCommon Stock 20 $119.76 $2,395.20
Disclosure

SEC source: 0001237334-26-000004 · primarydocument.xml · nonDerivative · entry 1

CAUSEY CHRISTOPHER · CIK 0001237334 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,210

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.

Read SEC document
March 03, 2026 Filed Mar 3, 2026 21:31 UTC
MALCOLM JANDirector
SaleCommon Stock 50 $509.20 $25,460.00
Disclosure

SEC source: 0002028640-26-000005 · primarydocument.xml · nonDerivative · entry 1

MALCOLM JAN · CIK 0002028640 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 170

F1 · kind: This is a sale of common stock pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on September 11, 2025.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 21:33 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
Exercise / conversionStock Option · Derivative 9,500 $0.00 Strike: $146.03 $0.00
Disclosure

SEC source: 0001106578-26-000003 · primarydocument.xml · derivative · entry 23

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 221,000

Underlying: Common Stock · 9,500 shares

Expires 2027-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 21:33 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 421 $507.09 $213,485.02
Disclosure

SEC source: 0001106578-26-000003 · primarydocument.xml · nonDerivative · entry 17

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F17 · price: This transaction was executed in multiple trades at prices ranging from $507.02 to $507.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 21:33 UTC
ROTHBLATT MARTINE ADirector · Chairperson & CEO
SaleCommon Stock 132 $506.16 $66,812.75
Disclosure

SEC source: 0001106578-26-000003 · primarydocument.xml · nonDerivative · entry 16

ROTHBLATT MARTINE A · CIK 0001106578 · Director · Chairperson & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 551

F1 · kind: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.

F16 · price: This transaction was executed in multiple trades at prices ranging from $505.85 to $506.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.